Sculptra Biostimulator

Gradual collagen stimulation for long-lasting volume and lift

Sculptra is not a traditional filler — it is a biostimulator containing poly-L-lactic acid (PLLA) that works by triggering your body's own collagen production. Results build gradually over 2–3 months and can last up to two years, making it ideal for patients wanting a long-term solution to volume loss.

Unlike hyaluronic acid fillers that provide immediate but temporary volume, Sculptra works progressively. Multiple sessions are typically spaced several weeks apart, with results continuing to improve as new collagen forms in the treated areas.

Key Benefits

Stimulates your own natural collagen for gradual, long-lasting results
Lasts up to two years — significantly longer than standard fillers
Provides full-face volumisation and skin quality improvement
Natural-looking build-up over 2–3 months

Is This Treatment Right For You?

Patients with significant facial volume loss wanting a long-term solution
Those wanting gradual results that colleagues won't notice
Adults wanting to stimulate their own collagen rather than use synthetic volume

What to Expect

Facial Volume Mapping

Areas of volume loss are assessed and a treatment plan is developed.

Session 1

Sculptra is injected and massaged into the target areas.

Follow-up Sessions

2–3 sessions spaced 4–6 weeks apart are typically needed.

Collagen Build Phase

Results progressively improve over 2–3 months as collagen forms.

Recovery & Aftercare

Swelling and possible bruising for a few days; massage of the treated area is required for several days post-treatment.

Frequently Asked Questions

Can Sculptra be dissolved if I don't like the result?

No — Sculptra is not reversible with hyaluronidase as it works by stimulating collagen rather than placing hyaluronic acid. Careful consultation and realistic expectations are essential.

How many Sculptra sessions are needed?

Typically 2–3 sessions for optimal results; younger patients with mild volume loss may need fewer sessions than older patients with more significant changes.